Childhood illnesses surge: Rebuilding trust key to tackling vaccine hesitancy
There are also many nasty illnesses such as whooping cough and measles that are preventable – but we are seeing rises in cases, sparking concern with public health officials.
A national whooping cough, or pertussis, epidemic was declared in November and more than 250 cases have been recorded across the Bay of Plenty and Lakes health districts.
Babies under 12 months old, whose mothers aren't immunised, are particularly at risk of infection because some are too young to have the vaccination themselves and will have a 50% chance of being hospitalised if infected.
So far this year in Bay of Plenty, 146 cases of whooping cough have been reported.
According to PHF Science, between October 19 last year and June 27 this year, 2635 probable, confirmed and suspected cases of whooping cough were notified nationally.
Whooping cough, which is highly infectious, is also under-reported as people often don't realise they have it or don't go to the doctor. Symptoms often start with a cough and a runny nose – similar to a cold.
Meanwhile, a measles outbreak in Wairarapa and Manawatū this month has shown just how nasty that disease also is, according to a paediatrician specialising in infectious diseases.
Dr Emma Best from the Immunisation Advisory Centre said measles 'seeks out' people and young children who were not immunised.
According to the US National Foundation for Infectious Diseases, measles is 'the most contagious virus known to humans'. It can result in seizures, deafness, blindness, permanent lung damage and immune amnesia (wiping out of prior immune protection).
Nationally, 77% of New Zealand children had received their childhood vaccinations by the age of 24 months in the three-month period ending December 31, 2024.
Vaccine scepticism, once a fringe distrust, has become more mainstream, especially under the shadow of Covid-19, when mandates and lockdowns damaged people's perceptions of the public health system – and indeed, science.
Hesitancy comes from fear, confusion or being overwhelmed – not malice. Nobody wants to see their children suffer.
However, shaming people is not the answer – rebuilding trust in public health is.
Empathy and transparency are needed to help people understand what's at stake.
Parents unsure about vaccines should be encouraged to speak to their trusted healthcare providers. GPs, schools and iwi also need to be part of the conversation.
Consistent messaging is also important, but we should recognise the burnout from the information bombardment during Covid's dark times.
We all have the same goals here, to keep our children and our families safe and healthy – so vital vaccine messaging needs to be inclusive, gentle and transparent.
Sign up to the Daily H, a free newsletter curated by our editors and delivered straight to your inbox every weekday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsroom
7 hours ago
- Newsroom
What pharmacists can do to help our mental health crisis
Opinion: The Covid-19 pandemic highlighted weaknesses and strengths in New Zealand's healthcare system. Community pharmacists emerged as one of its quiet powerhouses. When Level 4 restrictions hit in 2020 and many routine health services became inaccessible almost overnight, pharmacies stayed opened, adapting quickly and serving as a critical frontline for many communities. Pharmacists responded to a significant increase in prescription demand when there were disrupted supply chains, keeping essential medication supplies and management services, keeping communities connected and delivering vaccination services when it mattered most. This period offers profound insights into the capability of community pharmacists to pivot and support a public health system in crisis. As New Zealand confronts a deepening post-pandemic mental health crisis, a pressing question arises: can community pharmacists similarly help ensure there is prompt access to mental health support? We argue that community pharmacists are well-positioned to do so. According to the latest figures from the Pharmaceutical Society New Zealand, there are more than 1200 community pharmacies seeing about 1.3 million people each month in total. The very notion of community is embedded in the professional identity of community pharmacists; they are deeply integrated into the neighbourhoods and regions they serve. Unlike many healthcare professionals who are concentrated in urban hospitals or clinics, community pharmacists are accessible far beyond the main centres, including rural and remote areas. Pharmacists are often the most public-facing touchpoint in the healthcare system, providing a familiar and approachable setting. Pharmacists are funded to offer a range of physical health services for conditions such as diabetes, heart disease, hypertension, asthma, rheumatoid arthritis and chronic pain. They routinely inform and guide patients on medication use, adjust regimens, and monitor medication adherence. Pharmacists are also able to provide 'whole-of-life vaccinations' from children to older adults and, increasingly, to supply prescription-only medication without a prescription to support better access, such as for Covid-19 antivirals and Hepatitis C medication. If pharmacists are already trusted with the management of these complex, physical health conditions, why not include mental health as a priority funded service? Extending pharmacy services to mental health support would be a logical progression of the work community pharmacists already do. Their regular customers are often managing chronic health conditions that can be intertwined with mental health challenges. Physical illnesses such as diabetes, heart or respiratory disease often coexist with depression, anxiety, or insomnia, and treatment can be complicated by the interplay of physical and mental health symptoms. Pharmacists are therefore already well-positioned to help bridge the gap in current mental health service provision. Pharmacists receive rigorous training in the safe and effective use of medicines. Their education covers not only the pharmacological properties and interactions of drugs but also the broader principles of medication management, adherence, and patient counselling. This includes a focus on psychiatric medications – for example antidepressants, antipsychotics, mood stabilisers, and anxiolytics. Their ability to recognise and discuss potential side effects, monitor adherence, and identify risks, such as the dangers of abruptly stopping medication, is well-known. In practice, this expertise could translate into a range of supportive actions for people with mental health needs: pharmacists could initiate conversations about medication experiences, help manage side-effects, encourage ongoing adherence, and act as a first point of contact for mental health concerns or questions, thereby helping to prevent complications or relapses. Community pharmacists could also alert other clinicians such as general practitioners or specialist mental health services when more support may be needed. Pharmacists could also train to become pharmacist prescribers to support ongoing prescription of mental health medication in collaboration with a healthcare team. Indeed, pharmacists are increasingly being recognised as key community health professionals, and their role is expanding rapidly. Recent initiatives, such as the Expanded Pharmacist Prescribing Programme, aim to boost access to care, especially in rural and underserved communities, but they also position pharmacists as frontline providers of medicines management, patient education, and collaborative care. This evolution is part of a broader effort to modernise and diversify the health workforce, reduce pressure on GPs, and improve patient access to prompt care. This move thus reinforces the potential of community pharmacists to provide physical and mental health care. Research we and others have conducted in New Zealand with community pharmacists reveals enthusiasm about expanding their mental health role and interaction with customers. Many pharmacists see it as an opportunity to offer more mental health support as a natural extension of their commitment to holistic patient care. Pharmacists recognise the trust placed in them by the public and are motivated to provide more comprehensive support in collaboration with other clinicians and disciplines. In New Zealand, community pharmacists have been found to have good mental health literacy in identifying conditions such as depression and have positive attitudes towards those with mental illness and are willing to provide mental health support. If community pharmacists were involved in mental health care, it would lead to the early identification of mental health symptoms and improved continuity of care. It would also be professionally rewarding for pharmacists, enabling them to work to the top of their scope of practice. However, pharmacists have also expressed concerns: the need for additional training, clear protocols, shared digital/electronic health record platforms, safeguards to manage the complexity of mental health needs and funded pathways to provide such services. Additionally, there are legitimate concerns about time and space constraints, the boundaries of their professional role, and the availability of referral pathways for patients requiring more intensive support. These perspectives underscore the importance of careful planning and resourcing for any expansion of pharmacist-led mental health services. But this is achievable, and there are existing models of pharmacist-delivered mental health services, such as the Bloom programme in Canada. There are also social prescribing initiatives in the United Kingdom that involve community pharmacists together with other disciplines to provide support with health system navigation, harm reduction and person-centred care. In Australia, there are active trials evaluating the role of community pharmacies to provide physical and mental health support. In New Zealand, we will need more research and policy development to inform and guide effective models of care. We hope to collaborate closely with the community pharmacy sector to co-design a practical programme to suit various settings and communities, with careful evaluation of outcomes for patients and pharmacists. Such a programme would aim to build on existing strengths so that mental health support is accessible at the grassroots level. Community pharmacists are highly skilled and accessible healthcare professionals whose skills could be better deployed within the healthcare system. Many are drawn to the profession to serve and engage with their communities. By equipping them with the right resources and training, there is real potential to help address both the mental health crisis and the pressures on our overloaded healthcare system, and where pharmacies can truly function as a key healthcare hub in the community.
NZ Herald
a day ago
- NZ Herald
‘Working really hard': Whanganui child immunisation rates rise amid disease outbreaks
'Rates have risen from around 70% in late 2024 to around 77%. Notably, coverage for Māori children has also risen in that time from below 60% to around 75%.' Whanganui Regional Health Network (WRHN) and Te Oranganui said the results were due to hard work despite difficult circumstances, including the cost of living, lasting effects from Covid-19, and childhood disease outbreaks. At the start of July, a measles outbreak was detected in the Wairarapa area. It spread to Feilding with eight reported cases. Whanganui was identified as a hotspot for the whooping cough epidemic in November 2024 with a rate of infection at 11.4 cases per 100,000 people. 'We are really concerned,' WRHN immunisation co-ordinator Sue Hina said. She said there was some reluctance to immunisation 'from Covid-19 from when the ministry put in the mandates so people think 'don't tell me what to do'.' Te Oranganui chief executive Wheturangi Walsh-Tapiata said it was 'heartening' to see a recent increase in immunisations. 'It's been a challenging space to get whānau to understand the importance in particular of their child immunisations since Covid times,' she said. Hina said there had been increased focus on educating families to be able to make an informed decision on whether to immunise their children. 'That's making sure there's enough access for people, enough information for people, enough follow-up to those that are hesitant,' Hina said. 'People have the right to decline but we want to get to the point where the people declining can have a conversation with us.' She said the cost of living crisis had also placed barriers for struggling families to get immunised. 'The social determinants make a big difference; if you haven't got a house to live in or you can't pay your rent or put food on the table, you're less likely to be worried about whether your immunisations get done or not,' Hina said. Walsh-Tapiata said it was important to talk to people in their communities. 'The critical point of difference in terms of our services is that we go to them.' It was not only Te Oranganui that worked in this way to improve healthcare provision, but iwi Māori hauora providers throughout the region. 'There has been a really collective approach by the Iwi Māori Hauora providers throughout the region to address child immunisations initially and then overall immunisations,' Walsh-Tapiata said. Meanwhile, O'Connor said more work was needed to reach the 95% national target by 2030 but the progress was promising. 'And it is down to the tireless, collective efforts of our community and primary care provider partners, supported by the Whanganui Regional Health Network.' Olivia Reid is a multimedia journalist based in Whanganui.
NZ Herald
2 days ago
- NZ Herald
Childhood illnesses surge: Rebuilding trust key to tackling vaccine hesitancy
Schools, kindies, daycare centres and even workplaces are Petri dishes of diseases, forcing families to take time off work and school. The knock-on effects are many. There are also many nasty illnesses such as whooping cough and measles that are preventable – but we are seeing rises in cases, sparking concern with public health officials. A national whooping cough, or pertussis, epidemic was declared in November and more than 250 cases have been recorded across the Bay of Plenty and Lakes health districts. Babies under 12 months old, whose mothers aren't immunised, are particularly at risk of infection because some are too young to have the vaccination themselves and will have a 50% chance of being hospitalised if infected. So far this year in Bay of Plenty, 146 cases of whooping cough have been reported. According to PHF Science, between October 19 last year and June 27 this year, 2635 probable, confirmed and suspected cases of whooping cough were notified nationally. Whooping cough, which is highly infectious, is also under-reported as people often don't realise they have it or don't go to the doctor. Symptoms often start with a cough and a runny nose – similar to a cold. Meanwhile, a measles outbreak in Wairarapa and Manawatū this month has shown just how nasty that disease also is, according to a paediatrician specialising in infectious diseases. Dr Emma Best from the Immunisation Advisory Centre said measles 'seeks out' people and young children who were not immunised. According to the US National Foundation for Infectious Diseases, measles is 'the most contagious virus known to humans'. It can result in seizures, deafness, blindness, permanent lung damage and immune amnesia (wiping out of prior immune protection). Nationally, 77% of New Zealand children had received their childhood vaccinations by the age of 24 months in the three-month period ending December 31, 2024. Vaccine scepticism, once a fringe distrust, has become more mainstream, especially under the shadow of Covid-19, when mandates and lockdowns damaged people's perceptions of the public health system – and indeed, science. Hesitancy comes from fear, confusion or being overwhelmed – not malice. Nobody wants to see their children suffer. However, shaming people is not the answer – rebuilding trust in public health is. Empathy and transparency are needed to help people understand what's at stake. Parents unsure about vaccines should be encouraged to speak to their trusted healthcare providers. GPs, schools and iwi also need to be part of the conversation. Consistent messaging is also important, but we should recognise the burnout from the information bombardment during Covid's dark times. We all have the same goals here, to keep our children and our families safe and healthy – so vital vaccine messaging needs to be inclusive, gentle and transparent. Sign up to the Daily H, a free newsletter curated by our editors and delivered straight to your inbox every weekday.
